Jane L. Burrows

490 total citations
9 papers, 354 citations indexed

About

Jane L. Burrows is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Jane L. Burrows has authored 9 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Pharmaceutical Science and 2 papers in Molecular Biology. Recurrent topics in Jane L. Burrows's work include Inhalation and Respiratory Drug Delivery (7 papers), Drug Solubulity and Delivery Systems (3 papers) and Asthma and respiratory diseases (2 papers). Jane L. Burrows is often cited by papers focused on Inhalation and Respiratory Drug Delivery (7 papers), Drug Solubulity and Delivery Systems (3 papers) and Asthma and respiratory diseases (2 papers). Jane L. Burrows collaborates with scholars based in United Kingdom and United States. Jane L. Burrows's co-authors include Peter C. Seville, Tristan P. Learoyd, Mark E. Bunnage, Michael Yeadon, Russell A. Lewthwaite, Christelle Perros-Huguet, Timothy J. Evans, David Price, Iain Kilty and Christopher Phillips and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Jane L. Burrows

9 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane L. Burrows United Kingdom 9 182 134 86 71 64 9 354
Soon-Seok Hong South Korea 10 29 0.2× 144 1.1× 194 2.3× 40 0.6× 13 0.2× 11 433
Lei Ye China 10 17 0.1× 70 0.5× 120 1.4× 16 0.2× 17 0.3× 17 328
Shinichiro Tajiri Japan 6 16 0.1× 162 1.2× 192 2.2× 35 0.5× 14 0.2× 8 363
Fiona McCartney Ireland 13 39 0.2× 349 2.6× 207 2.4× 49 0.7× 9 0.1× 22 561
Y. John Wang United States 13 17 0.1× 98 0.7× 462 5.4× 23 0.3× 9 0.1× 14 600
María Plaza-Oliver Spain 9 12 0.1× 100 0.7× 90 1.0× 49 0.7× 14 0.2× 11 313
Vamshi Krishna Tippavajhala India 10 14 0.1× 167 1.2× 79 0.9× 44 0.6× 9 0.1× 50 342
João Basso Portugal 12 17 0.1× 68 0.5× 158 1.8× 25 0.4× 5 0.1× 18 409
Mainak Chakraborty India 9 23 0.1× 89 0.7× 125 1.5× 12 0.2× 29 0.5× 14 347
Tapash K. Ghosh United States 10 8 0.0× 293 2.2× 64 0.7× 49 0.7× 14 0.2× 18 387

Countries citing papers authored by Jane L. Burrows

Since Specialization
Citations

This map shows the geographic impact of Jane L. Burrows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane L. Burrows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane L. Burrows more than expected).

Fields of papers citing papers by Jane L. Burrows

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane L. Burrows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane L. Burrows. The network helps show where Jane L. Burrows may publish in the future.

Co-authorship network of co-authors of Jane L. Burrows

This figure shows the co-authorship network connecting the top 25 collaborators of Jane L. Burrows. A scholar is included among the top collaborators of Jane L. Burrows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane L. Burrows. Jane L. Burrows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jones, Lyn H., Jane L. Burrows, N. Feeder, et al.. (2015). Molecular hybridization yields triazole bronchodilators for the treatment of COPD. Bioorganic & Medicinal Chemistry Letters. 25(22). 5121–5126. 9 indexed citations
2.
Millan, David S., Mark E. Bunnage, Jane L. Burrows, et al.. (2011). Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of Medicinal Chemistry. 54(22). 7797–7814. 76 indexed citations
3.
Glossop, Paul A., David Price, Mark E. Bunnage, et al.. (2010). Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup. Journal of Medicinal Chemistry. 53(18). 6640–6652. 65 indexed citations
4.
Learoyd, Tristan P., et al.. (2010). Sustained delivery of salbutamol and beclometasone from spray-dried double emulsions. Journal of Microencapsulation. 27(2). 162–170. 9 indexed citations
5.
Learoyd, Tristan P., et al.. (2009). Sustained delivery by leucine-modified chitosan spray-dried respirable powders. International Journal of Pharmaceutics. 372(1-2). 97–104. 44 indexed citations
6.
Learoyd, Tristan P., et al.. (2009). Sustained delivery of salbutamol and beclometasone from spray-dried double emulsions. Journal of Microencapsulation. 27(2). 192883490–192883490. 11 indexed citations
7.
Learoyd, Tristan P., et al.. (2008). Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders. Powder Technology. 187(3). 231–238. 41 indexed citations
8.
Learoyd, Tristan P., et al.. (2007). Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. European Journal of Pharmaceutics and Biopharmaceutics. 68(2). 224–234. 90 indexed citations
9.
Horwich, Robert H., et al.. (1982). Seasonal variation in mother‐daughter groupings in Siberian ibex (Capra ibex siberica). Zoo Biology. 1(4). 345–354. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026